Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying effect modifiers of systemic hydrocortisone treatment initiated 7-14 days after birth in ventilated very preterm infants on long-term outcome: secondary analysis of a randomised controlled trial.
Halbmeijer NM, Sonnaert M, Swarte RM, Koopman-Esseboom C, van Stuijvenberg M, Mulder-de Tollenaer S, Tan RNGB, Mohns T, Bruneel E, Steiner K, Kramer BW, Debeer A, van Weissenbruch MM, Marechal Y, Blom H, Plaskie K, Offringa M, Merkus MP, Onland W, Leemhuis AG, van Kaam AH; SToP-BPD Study group. Halbmeijer NM, et al. Among authors: mulder de tollenaer s. Arch Dis Child Fetal Neonatal Ed. 2024 Feb 19;109(2):159-165. doi: 10.1136/archdischild-2023-325558. Arch Dis Child Fetal Neonatal Ed. 2024. PMID: 37722765 Clinical Trial.
Short-term pulmonary and systemic effects of hydrocortisone initiated 7-14 days after birth in ventilated very preterm infants: a secondary analysis of a randomised controlled trial.
Halbmeijer NM, Onland W, Cools F, Kroon A, van der Heide-Jalving M, Dijk P, van Straaten HLM, Te Pas AB, Mohns T, Bruneel E, van Heijst AFJ, Kramer B, Debeer A, Zonnenberg IA, Marechal Y, Blom H, Plaskie K, Merkus MP, Offringa M, van Kaam AH; SToP-BPD Study Group; STOP-BPD Study Group. Halbmeijer NM, et al. Arch Dis Child Fetal Neonatal Ed. 2023 Jan;108(1):20-25. doi: 10.1136/archdischild-2022-323882. Epub 2022 May 9. Arch Dis Child Fetal Neonatal Ed. 2023. PMID: 35534184 Clinical Trial.
Effect of systemic hydrocortisone in ventilated preterm infants on parent-reported behavioural outcomes at 2 years' corrected age: follow-up of a randomised clinical trial.
Halbmeijer NM, Onland W, Cools F, Swarte RM, van der Heide-Jalving M, Dijk P, Mulder-de Tollenaer S, Tan RNGB, Mohns T, Bruneel E, van Heijst AFJ, Kramer B, Debeer A, van Weissenbruch MM, Marechal Y, Blom H, Plaskie K, Offringa M, van Wassenaer-Leemhuis AG, van Kaam AH, Aarnoudse-Moens CSH; SToP-BPD study group. Halbmeijer NM, et al. Among authors: mulder de tollenaer s. Arch Dis Child Fetal Neonatal Ed. 2023 Jul;108(4):373-379. doi: 10.1136/archdischild-2022-324179. Epub 2023 Jan 2. Arch Dis Child Fetal Neonatal Ed. 2023. PMID: 36593110 Clinical Trial.
Two-year neurodevelopmental outcome in children born extremely preterm: the EPI-DAF study.
van Beek PE, Rijken M, Broeders L, Ter Horst HJ, Koopman-Esseboom C, de Kort E, Laarman C, Mulder-de Tollenaer SM, Steiner K, Swarte RM, van Westering-Kroon E, Oei SG, Leemhuis AG, Andriessen P; EPI-DAF study group. van Beek PE, et al. Among authors: mulder de tollenaer sm. Arch Dis Child Fetal Neonatal Ed. 2022 Sep;107(5):467-474. doi: 10.1136/archdischild-2021-323124. Epub 2022 Mar 2. Arch Dis Child Fetal Neonatal Ed. 2022. PMID: 35236745 Free PMC article.
Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus.
Hundscheid T, Onland W, Kooi EMW, Vijlbrief DC, de Vries WB, Dijkman KP, van Kaam AH, Villamor E, Kroon AA, Visser R, Mulder-de Tollenaer SM, De Bisschop B, Dijk PH, Avino D, Hocq C, Zecic A, Meeus M, de Baat T, Derriks F, Henriksen TB, Kyng KJ, Donders R, Nuytemans DHGM, Van Overmeire B, Mulder AL, de Boode WP; BeNeDuctus Trial Investigators. Hundscheid T, et al. Among authors: mulder de tollenaer sm. N Engl J Med. 2023 Mar 16;388(11):980-990. doi: 10.1056/NEJMoa2207418. Epub 2022 Dec 6. N Engl J Med. 2023. PMID: 36477458 Clinical Trial.
Neurodevelopmental outcomes at five years after early-onset fetal growth restriction: Analyses in a Dutch subgroup participating in a European management trial.
Pels A, Knaven OC, Wijnberg-Williams BJ, Eijsermans MJC, Mulder-de Tollenaer SM, Aarnoudse-Moens CSH, Koopman-Esseboom C, van Eyck J, Derks JB, Ganzevoort W, van Wassenaer-Leemhuis AG. Pels A, et al. Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:63-70. doi: 10.1016/j.ejogrb.2018.12.041. Epub 2019 Jan 11. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 30660941
[Two-year follow-up of infants born at 24 weeks gestation; first outcomes following implementation of the new 'Guideline for perinatal policy in cases of extreme prematurity'].
Aarnoudse-Moens CSH, Rijken M, Swarte RM, Andriessen P, Ter Horst HJ, Mulder-de Tollenaer SM, Koopman-Esseboom C, Laarman ARC, Steiner K, van der Hoeven AHBM, Kornelisse RF, Duvekot JJ, Weisglas-Kuperus N. Aarnoudse-Moens CSH, et al. Ned Tijdschr Geneeskd. 2017;161:D1168. Ned Tijdschr Geneeskd. 2017. PMID: 28589868 Dutch.
OPtimal TIming of antenatal COrticosteroid administration in pregnancies complicated by early-onset fetal growth REstriction (OPTICORE): study protocol of a multicentre, retrospective cohort study.
van de Meent M, Kleuskens DG, Ganzevoort W, Gordijn SJ, Kooi EMW, Onland W, van Rijn BB, Duvekot JJ, Kornelisse RF, Al-Nasiry S, Jellema RK, Knol HM, Manten GTR, Mulder-de Tollenaer SM, Derks JB, Groenendaal F, Bekker MN, Schuit E, Lely AT, Kooiman J. van de Meent M, et al. Among authors: mulder de tollenaer sm. BMJ Open. 2023 Mar 17;13(3):e070729. doi: 10.1136/bmjopen-2022-070729. BMJ Open. 2023. PMID: 36931680 Free PMC article.
22 results